Cytochemical markers and DNA content of neuroendocrine cells in carcinoma of the prostate gland during tumour progression.
Falkmer
S
S
Department of Tumour Pathology, Karolinska Institute and Hospital, Sweden.
Askensten
U
U
Grimelius
L
L
Abrahamsson
P A
PA
D000230:Adenocarcinoma / Q000473:pathology*; D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis*; D004273:DNA, Neoplasm / Q000032:analysis*; D005500:Follow-Up Studies; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D008875:Middle Aged; D009479:Neuropeptides / Q000032:analysis*; D009490:Neurosecretory Systems / Q000473:pathology; D011471:Prostatic Neoplasms / Q000473:pathology*; D012701:Serotonin / Q000032:analysis
D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; D009479:Neuropeptides; D012701:Serotonin